KLRB1 and autoimmune disease: Stimulation of CD39 and CD161 further amplifies ASM-mediated mTOR and STAT3 signals, which eventually drive Th17 generation.30 These findings suggest a novel cellular link between transmembrane proteins such as CD39/CD161 and ASM-dependent ceramide signals in driving Th17 expansion in autoimmune diseases.